| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Strongyloidiasis is a chronic infection that may result in significant morbidity; however, diagnosis and management remain problematic. The objective of this study was to 1) evaluate the demographic, clinical, and laboratory features of 76 consecutive individuals who had Strongyloides stercoralis larvae identified in their fecal specimens; 2) determine the sensitivity of the Centers for Disease Control and Prevention (CDC) enzyme immunoassay (EIA) for detecting antibodies to Strongyloides in those with confirmed infection; and 3) assess the serologic responses and changes in eosinophil counts following treatment. Most (96%) cases occurred in immigrants, but some patients had immigrated as long as 40 years earlier. The CDC Strongyloides EIA had a sensitivity of 94.6% (95% confidence interval = 92.0-97.2%) in this patient population with proven infection. Serologic and eosinophil counts decreased after therapy, suggesting that they may be useful markers of treatment success.
This article has been cited by other articles:
|
|
 |
|
  F. Verzegnassi, R. M. Boucher, L. Gilbert-McClain, B. Chowdhury, D. R. Boulware, W. M. Stauffer III, P. F. Walker, M. E. Rothenberg, P. F. Weller, and A. Klion Hypereosinophilic syndrome and mepolizumab. N. Engl. J. Med., June 26, 2008; 358(26): 2838 - 2838. [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Page and J. Zenilman Eosinophilia in a Patient From South America JAMA, January 30, 2008; 299(4): 437 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Segarra-Newnham Manifestations, Diagnosis, and Treatment of Strongyloides stercoralis Infection Ann. Pharmacother., December 1, 2007; 41(12): 1992 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Franco-Paredes, R. Dismukes, D. Nicolls, A. Hidron, K. Workowski, A. Rodriguez-Morales, M. Wilson, D. Jones, P. Manyang, and P. Kozarsky Persistent and Untreated Tropical Infectious Diseases Among Sudanese Refugees in the United States Am J Trop Med Hyg, October 1, 2007; 77(4): 633 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Boscolo, M. Gobbo, W. Mantovani, M. Degani, M. Anselmi, G. B. Monteiro, S. Marocco, A. Angheben, M. Mistretta, M. Santacatterina, et al. Evaluation of an Indirect Immunofluorescence Assay for Strongyloidiasis as a Tool for Diagnosis and Follow-Up Clin. Vaccine Immunol., February 1, 2007; 14(2): 129 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. YORI, M. KOSEK, R. H. GILMAN, J. CORDOVA, C. BERN, C. B. CHAVEZ, M. P. OLORTEGUI, C. MONTALVAN, G. M. SANCHEZ, B. WORTHEN, et al. SEROEPIDEMIOLOGY OF STRONGYLOIDIASIS IN THE PERUVIAN AMAZON Am J Trop Med Hyg, January 1, 2006; 74(1): 97 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Newberry, D. N. Williams, W. M. Stauffer, D. R. Boulware, B. R. Hendel-Paterson, and P. F. Walker Strongyloides Hyperinfection Presenting as Acute Respiratory Failure and Gram-Negative Sepsis Chest, November 1, 2005; 128(5): 3681 - 3684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lim, K. Katz, S. Krajden, M. Fuksa, J. S. Keystone, and K. C. Kain Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management Can. Med. Assoc. J., August 31, 2004; 171(5): 479 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. ROMAN-SANCHEZ, A. PASTOR-GUZMAN, S. MORENO-GUILLEN, R. IGUAL-ADELL, S. S. ER-GENEROSO, and C. TORNERO-ESTEBANEZ HIGH PREVALENCE OF STRONGYLOIDES STERCORALIS AMONG FARM WORKERS ON THE MEDITERRANEAN COAST OF SPAIN: ANALYSIS OF THE PREDICTIVE FACTORS OF INFECTION IN DEVELOPED COUNTRIES Am J Trop Med Hyg, September 1, 2003; 69(3): 336 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Antibodies and Eosinophils: Diagnosis and Follow-Up in Strongyloidiasis Journal Watch Infectious Diseases, October 11, 2002; 2002(1011): 6 - 6. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
